Litfulo
My Prescription
Payment
Select pharmacy
$4,532.43
$30.00 due at pharmacy
$4,532.43 - $30.00 = $4,502.43
$4,502.43 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
AlbertsonsPowered by$4,532.43
Print or send this coupon to your phone
AlbertsonsPowered byAbout Litfulo
Drug Details
Litfulo (ritlecitinib) is prescribed to treat alopecia areata, an autoimmune disorder that leads to hair loss. This medication is suitable for adults and children 12 years and older. As a kinase inhibitor, Litfulo works by interfering with specific enzymes that play a role in the immune system's attack on hair follicles. It is taken orally in capsule form once daily. Common side effects may include headache and diarrhea. Always consult with a healthcare professional before starting any new medication to ensure it is appropriate for your condition.
Price history for Litfulo
28 Capsules, 50MG
Average retail price for Litfulo
Average SaveHealth price for Litfulo
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Litfulo dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 50MG | 28 Capsules | $4,532.43 | $161.87 |
Litfulo FAQs
Litfulo (ritlecitinib) is a medication that has been studied for its potential use in treating alopecia areata, an autoimmune condition that causes hair loss. Clinical trials have shown that it can be effective in promoting hair regrowth in individuals with this condition. However, its effectiveness for other types of hair loss, such as androgenetic alopecia, is not established. It is important for individuals to consult with a healthcare provider to determine the most appropriate treatment for their specific type of hair loss.
Litfulo is a medication developed by Pfizer, known generically as ritlecitinib. It is used for the treatment of alopecia areata, an autoimmune condition that causes hair loss. Ritlecitinib is a Janus kinase (JAK) inhibitor, which works by modulating the immune system to reduce inflammation and prevent hair loss.
Litfulo (ritlecitinib) has shown promising results in clinical trials for the treatment of alopecia areata, an autoimmune condition that causes hair loss. In studies, a significant number of patients experienced substantial hair regrowth after using Litfulo. However, individual responses can vary, and it is important for patients to discuss with their healthcare provider to determine if it is an appropriate treatment option for their specific condition.
Litfulo (ritlecitinib) is primarily indicated for the treatment of alopecia areata, an autoimmune condition that causes patchy hair loss. It is not specifically approved for general thinning hair or other types of hair loss. It is important for individuals to consult with a healthcare provider to determine the appropriate treatment for their specific condition.
The high cost of Litfulo can be attributed to several factors. These include the extensive research and development required to bring the medication to market, the costs associated with clinical trials, and the regulatory approval process. Additionally, the pricing may reflect the drug's effectiveness, the complexity of its manufacturing process, and the investment needed to ensure its safety and efficacy. Market exclusivity and patent protection can also play a role in the pricing strategy.